Решение проблемы нарушенного микробиоценоза у детей с синдромом раздраженного кишечника


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Доступ платный или только для подписчиков

Аннотация

Терапия современными пробиотиками приобретает особое значение практически при любых острых и хронических заболеваниях, сопровождающихся дисфункцией микробиоценоза и кишечного барьера. В статье приводятся данные о роли микробных сообществ в развитии синдрома раздраженного кишечника. Необходимость применения пробиотиков остается более чем актуальной ввиду их эффективности, безопасности и широкой доступности. Представлены результаты исследований с использованием штамма Lactobacillus rhamnosus в разнообразных клинических ситуациях.

Полный текст

Доступ закрыт

Об авторах

Н. И Урсова

Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского

д.м.н., проф., рук. педиатрической клиники МОНИКИ им. М.Ф. Владимирского, зав. кафедрой педиатрии ФУВ МОНИКИ

Список литературы

  1. Drossman D.A., Chang L., et al. Rome I.V., functional gastrointestinal disorders, disorders of gut-brain interaction. Fouth, The Rome Foundation, Raleigh (NC). 2016.
  2. Filipovic B., Forbes A., Tepes B. Current approaches to the functional gastrointestinal disorders. Gastroenterol Res Pract 2017,2017:4957154. doi: 10.1155/2017/4957154.
  3. Drossman D.A Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV Gastroenterology. 2016;150(6):1262-79. doi: 10.1053/j.gastro.2016.02.032.
  4. Lacy B.E., Mearin F., Chang L., et al. Bowel disorders. Gastroenterology. 2016;150:1393-407. doi: 10.1053/j.gastro.2016.02.031.
  5. Carabotti M., Scirocco A., Maselli M.A., Seven C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol 1015;28:203-25.
  6. Phipott H., Gibson P., Thien F. Irritable bowel syndrome - an inflammatory disease involving mast cell. Asia Pac Allergy. 2011;1(1):36-42. doi: 10.5415/apallergy. 2011.1.1.36.
  7. Kennedy P.J., Cryan J.F., Dinan T.G., Clarke G. Irritable bowel syndrome: a microbiome-gutbrain axis disorder? World J Gastroenterol. 2014;20(39):14105-25. doi: 10.3748/wjg.v20. i.39.14105.
  8. Kovacic K. Current concepts in functional gastrointestinal disorders. Curr Opin Pediatr. 2015;27(5):619-24. Doi: 10.109 7/ MOP.0000000000000262.
  9. De Palma G., Collins S.M., Bercik P., Verdu E.F. The microbiota-gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both? J Physiol. 2014;592:2989-97. Doi: 10.1113/ jphysiol.2014.273995.
  10. Clarke G., Grenham S., Scully P, et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonengic system in a sex-dependent manner Mol Psychiatry. 2013;18(6):666-73. doi: 10.1038/mp.2012.77.
  11. Yu L.C., Wang Jt., Wei S.C., Ni Y.H. Host-microbial interactions and regulation of intestinal epithelial barrier function: From physiology to pathology. World J Gastrointest Pathophysiol. 2012;3(1):27-43. doi: 10.4291/wjgp.v3.i1.27.
  12. Shafquat A., Joice R., Simmons S.L., Huttenhower C. Functional and phylogenetic assembly of microbial communities in the human microbiome. Trends Microbiol. 2014;22(5):261-66. Doi: 10.1016/]. tim.2014.01.011.
  13. Cullen T.W., Schofield W.B., Barry N.A., et al. Gut microbiota. Antimicrobial peptide resistance mediates resilience of prominent gut commensals during inflammation. Science. 2015;347(6218):170-75. doi: 10.1126/science.1260580.
  14. Magnusdottir S., Ravcheev D., de Crecy-Lagard V., Thiele I. Systematic genome assessment of B-vitamin biosynthesis suggests co-operation among gut microbes. Front Genet 2015;6:148. Doi: 10.3389/ fgene.2015.00148.
  15. Neis E.P., Dejong C.H., Rensen S.S. The role of microbial amino acid metabolism in host metabolism. Nutrients. 2015;7(4):2930-46. Doi: 10.3390/ nu7042930.
  16. Sagar N.M., Gree I.A., Covington J.A., Arasaradnam R.P. The interplay of the gut microbiome, bile acids, and volatile organic compounds. Gastroenterol Res Pract. 2015;2015:398585. doi: 10.1155/2015/398585.
  17. Pozuelo M., Panda S., Santiago A., et al. Reduction of butyrate- and methane-producing microorganisms in patients with irritable bowel syndrome. Sci Rep. 2015;5:12693. doi: 10.1038/srep12693.
  18. Ford A.C., Spiegel B.M., Talley N.J., Moaguedi P. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009;7:1279-86. doi: 10.1016/j.cgh.2009.06.031.
  19. Shelley H., Brennan M., Heuschkel R. Hydrogen breath testing in children: what is it and why is it performed? Castroint Nurs. 2009;7:18-27.
  20. Lozupone C.A., Stombaugh J.I., Gordon Ji., et al. Diversity, stability and resilience of the human gut microbiota. Nature 2012;489(7415):220-30. doi: 10.1038/nature11550
  21. Dore J., Corthier G. The human intestinal microbiota. Gastroenterol Clin Biol. 2010;34:7-15. doi: 10.1016/S0399-8320(10)70015-4.
  22. Salonen A., Salojarvi J., Lahti L., de Vos W.M. The adult intestinal core microbiota is determined by analysis depth and health status. Clin Microbiol Infect. 2012;18(4):16-20. doi: 10.1111/j.1469-0691.2012.03855.x.
  23. Hemarajata P., Versalovic J. Effect of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therap Adv Gastroenterol. 2013;6(1):39-51. doi: 10.1177/1756283X12459294.
  24. Whelan K., Quigley E.M. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Curr Opin Gastroenterol. 2013;29(2):184-89. Doi.: 10.1097/MOG.0b013e32835d7bba.
  25. Moayyedi P, Ford A.C., Talley N.J., et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: asystematic review. Gut. 2010;59(3):325-32.
  26. Mercenier A., Pavan S., Pot B. Probiotics as biotherapeutic agent: present khuwledge and future prospects. CurrPharm Des. 2003;9:175-91.
  27. Timmerman H.M., Koning C.J.M., Mulder L., et al. Monostrain, multistrain and multispecies probiotics. A comparison of functionality and efficacy. Int J Food Microbiol. 2004;96:219-33.
  28. Medzhitov R. Toll-like receptors and innate immunity. Nature Reviews Immunology. 2001;1(2):143-45.
  29. Walter J. Ecological role of lactobacilli in the gastrointestinal tract: implication for fundamental and biomedical research. Appl Envir Microbiol. 2008;74(16):4985-96.
  30. Vinderola G., Matar C., Perdigon G. Role of intestinal epithelial cells in immune effects mediated by gram-positive probiotic bacteria: involvement of toll-like receptors. Clin Diagn Lab Immunol. 2005;12(9):1075-84.
  31. Vesikari T., Uhari M., Renko M., et al. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of rotavirus immunization program in Finland. Pediatr Infect Dis J. 2013;32(12):1365-73. Doi: 10.1097/ INF.0000000000000086.
  32. Szajewska H., Mrukowicz.J. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo controlled trials. J Pediatr Gastroenterol Nutr. 2001;33:17-25.
  33. Bezkorovainy A. Probiotics: determinants of survival and growth in the gut. Am J Clin Nutr. 2001;73:399-405. doi: 10.1093/ajcn/73.2.399s.
  34. Guarino A., Albano F., Ashkenazi Sh., et al. European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases Evidence-based Guidelines for the Management of Acute Gastroeteritis in Children in Europe. J of Pediatric Gastroenterology and Nutrition. 2008;46:81-184.
  35. Roberfroid M. Prebiotics: the concept revisited. J Nutr. 2007;137(3):830-37. Doi: 10.1093/ jn/137.3.830S.
  36. Roberfroid M., Robertson D. Effect of inulin and oligofructose on health and well-being. Brit J Nutr. 2005;9(1):1-27.
  37. Floch M.H., Walker W.A., Sanders M., et al. Recommendation for Probiotic Use - 2015 Update: Proceedings and consensus Opinion. J Clin Gastroenterol. 2015;49(1):69-73. Doi: 10.1097/ MCG.0000000000000420.
  38. Horvath A., Dziechciarz P., Szayewska H. Metaanalysis: Lactobacillus rhamnosus GG in functional gastrointestinal disoders associated with abdominal pain in childhood. Alimentary Pharmacology and Therapeutics. 2013;3:1302-10. doi: 10.1111/j.1365-2036.2011.04665.x.
  39. Hojsak I., Snovak N., Abdovic S., et al. Lactobacillus GG in the prevention og gastrointestinal and respiratory tract infections in children who attend care centers a randomized, double-blind, placebo controlled trial. Clin Nutr. 2010;29(3):312-16.
  40. Kianifar H., Jafari S.A., Kiani M., et al. Probiotic for irritable bower syndrome in pediatrics patients a randomized controlled clinical trial. Electron Physician. 2015;7(5):1255-60. doi: 10.14661/1255.
  41. Derrien M., van Hylckama Vieg J.E.T. Fate, activity, and impact of ingested bacteria within the human gut microbiota. Trends Microbiol. 2015;23(6):354-66. doi: 10.1016/j.tim.2015.03.002.
  42. Sanders M.E. Impact of probiotics on colonizing microbiota of the gut. J Clin Gastroenterol. 2011;45(3):115-19. Doi: 10.1097/ MCG.0b013e318227414a.
  43. Martens U., Enck P., Zieseniss P. Probiotic treatment of irritable bowel syndrome in children. Ger Med Sci. 2010;8:1-15. doi: 10.3205/000096.
  44. Quigley E.M., Abdel-Hamid H., Barbara G., et al. A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome. J Clin Gastroenterol. 2012;46(5):356-66. doi: 10.1097/MCG.0b013e318247157c.
  45. Simren M., Barbara G., Flint H.J., et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut. 2013;62(1):159-76. doi: 10.1136/gutjnl-2012-302167.
  46. Cruchet S., Furnes R., Maruy A., et al. The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by latin-american experts. Paediatr Drugs. 2015;17(3):199-216. doi: 10.1007/s40272-015-0124-6.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ООО «Бионика Медиа», 2019

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах